COULTER PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-02
PHARMACEUTICAL PREPARATIONS
Previous: COULTER PHARMACEUTICALS INC, 10-Q, 2000-11-02
Next: SULLIVAN JOSEPH P, 4, 2000-11-02



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          44,726
<SECURITIES>                                    37,953
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                94,815
<PP&E>                                          25,736
<DEPRECIATION>                                   6,231
<TOTAL-ASSETS>                                 115,710
<CURRENT-LIABILITIES>                           22,340
<BONDS>                                          8,086
                                0
                                          0
<COMMON>                                            19
<OTHER-SE>                                      85,265
<TOTAL-LIABILITY-AND-EQUITY>                   115,710
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                51,250
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 815
<INCOME-PRETAX>                               (39,999)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (39,999)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (39,999)
<EPS-BASIC>                                     (2.32)
<EPS-DILUTED>                                   (2.32)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission